Merck Hong Kong’s Hee-sun Lee gives her first impressions of the Hong Kong market, her main priorities, upcoming product launches and tapping into the territory’s R&D ecosystem.
Hee-sun, having joined Merck Pharmaceutical Hong Kong in February 2018 from the South Korean affiliate, what are your first impressions of the market compared to South Korea?
"I am extremely excited about the number of great product launches for Merck globally, which will also be launched in Hong Kong soon to benefit patients here"
